HOTH Q1 2019 Earnings — Hoth Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HOTHHoth Therapeutics, Inc.

$15M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$7,029

Operating Income

-$829,365

Net Income

-$829,365

EPS (Diluted)

$-2.96

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$763,955

Free Cash Flow

-$773,955

Stock-Based Comp.

$202,709

Balance Sheet

Total Assets

$5M

Total Liabilities

$87,925

Stockholders' Equity

$5M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$7,029	$0	—
Operating Income	-$829,365	-$527,546	-57.2%
Net Income	-$829,365	-$527,546	-57.2%